TuisEVGN • NASDAQ
add
Evogene Ltd
Vorige sluiting
$1,11
Dagwisseling
$1,09 - $1,14
Jaarwisseling
$0,95 - $8,90
Markkapitalisasie
7,23 m USD
Gemiddelde volume
739,16 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,61 m | 178,72% |
Bedryfskoste | 5,92 m | -24,14% |
Netto inkomste | 427,00 k | 106,47% |
Netto winsgrens | 26,51 | 102,32% |
Wins per aandeel | 0,06 | 104,62% |
EBITDA | -4,47 m | 35,76% |
Effektiewe belastingkoers | 350,00% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 15,31 m | -50,71% |
Totale bates | 39,86 m | -21,99% |
Totale aanspreeklikheid | 25,03 m | 11,64% |
Totale ekwiteit | 14,84 m | — |
Uitstaande aandele | 6,51 m | — |
Prys om te bespreek | -5,05 | — |
Opbrengs op bates | -31,68% | — |
Opbrengs op kapitaal | -83,71% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 427,00 k | 106,47% |
Kontant van bedrywe | -5,21 m | 12,12% |
Kontant van beleggings | 8,76 m | 1 594,54% |
Kontant van finansiering | 440,00 k | 399,32% |
Netto kontantverandering | 3,98 m | 160,74% |
Beskikbare kontantvloei | -9,20 m | -148,92% |
Meer oor
Evogene is a computational biology company based in Israel, specializing in predictive biology platforms that leverage artificial intelligence and machine learning for life-science product development. Evogene's platforms focus on designing novel microbes, small molecules, and genetic elements for use in pharmaceuticals, agriculture, and related industries. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
HUB
Gestig
2002
Webwerf
Werknemers
117
